CRYL1 and cancer: Its predicted protein sequence exhibited ~19% pairwise identity to the 95-kDa-aphidicidal protein (sequence 204) described in patent US 8318900 (accession no. AGA40064) [9] and ~40% pairwise identity to cancer cell killing Cry proteins (parasporins Cry41Ab1 and Cry41Aa) [19] (Figure 1).